Targeting histone methyltransferase EZH2 as cancer treatment
Y Kondo - The journal of biochemistry, 2014 - academic.oup.com
It is widely accepted that epigenetic alterations are associated with different stages of tumour
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
[PDF][PDF] JB Review Targeting histone methyltransferase EZH2 as cancer treatment
Y Kondo - J. Biochem, 2014 - scholar.archive.org
It is widely accepted that epigenetic alterations are associated with different stages of tumour
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
Targeting histone methyltransferase EZH2 as cancer treatment.
Y Kondo - Journal of Biochemistry, 2014 - search.ebscohost.com
It is widely accepted that epigenetic alterations are associated with different stages of tumour
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
[引用][C] JB Review: Targeting histone methyltransferase EZH2 as cancer treatment
Y Kondo - The journal of biochemistry, 2014 - cir.nii.ac.jp
JB Review : Targeting histone methyltransferase EZH2 as cancer treatment | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Targeting histone methyltransferase EZH2 as cancer treatment.
Y Kondo - Journal of Biochemistry, 2014 - europepmc.org
It is widely accepted that epigenetic alterations are associated with different stages of tumour
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
Targeting histone methyltransferase EZH2 as cancer treatment
Y Kondo - Journal of biochemistry, 2014 - pubmed.ncbi.nlm.nih.gov
It is widely accepted that epigenetic alterations are associated with different stages of tumour
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
formation and progression in many cancers. Therefore, epigenetic abnormalities in cancers …
[引用][C] Targeting histone methyltransferase EZH2 as cancer treatment
Y Kondo - J Biochem, 2014 - cir.nii.ac.jp
Targeting histone methyltransferase EZH2 as cancer treatment | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …